| Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. JS Gonzalez, ML Tanenbaum, PV Commissariat American Psychologist 71 (7), 539, 2016 | 322 | 2016 |
| Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets ML Tanenbaum, SJ Hanes, KM Miller, D Naranjo, R Bensen, KK Hood Diabetes care 40 (2), 181-187, 2017 | 255 | 2017 |
| Diabetes burden and diabetes distress: the buffering effect of social support RN Baek, ML Tanenbaum, JS Gonzalez Annals of Behavioral Medicine 48 (2), 145-155, 2014 | 225 | 2014 |
| Diabetes technology: improving care, improving patient‐reported outcomes and preventing complications in young people with Type 1 diabetes P Prahalad, M Tanenbaum, K Hood, DM Maahs Diabetic Medicine 35 (4), 419-429, 2018 | 132 | 2018 |
| “Does that make me a woman?” Breast cancer, mastectomy, and breast reconstruction decisions among sexual minority women LR Rubin, M Tanenbaum Psychology of Women Quarterly 35 (3), 401-414, 2011 | 122 | 2011 |
| Expectations and attitudes of individuals with type 1 diabetes after using a hybrid closed loop system E Iturralde, ML Tanenbaum, SJ Hanes, SC Suttiratana, JM Ambrosino, ... The Diabetes Educator 43 (2), 223-232, 2017 | 108 | 2017 |
| Diabetes technology: uptake, outcomes, barriers, and the intersection with distress D Naranjo, ML Tanenbaum, E Iturralde, KK Hood Journal of diabetes science and technology 10 (4), 852-858, 2016 | 104 | 2016 |
| Optimal use of diabetes devices: clinician perspectives on barriers and adherence to device use ML Tanenbaum, RN Adams, SJ Hanes, RC Barley, KM Miller, ... Journal of diabetes science and technology 11 (3), 484-492, 2017 | 97 | 2017 |
| Cost, hassle, and on-body experience: barriers to diabetes device use in adolescents and potential intervention targets LH Messer, ML Tanenbaum, PF Cook, JJ Wong, SJ Hanes, KA Driscoll, ... Diabetes technology & therapeutics 22 (10), 760-767, 2020 | 92 | 2020 |
| Successful self‐management among non‐insulin‐treated adults with Type 2 diabetes: a self‐regulation perspective ML Tanenbaum, H Leventhal, JY Breland, J Yu, EA Walker, JS Gonzalez Diabetic Medicine 32 (11), 1504-1512, 2015 | 75 | 2015 |
| Diabetes distress from the patient's perspective: Qualitative themes and treatment regimen differences among adults with type 2 diabetes ML Tanenbaum, NS Kane, J Kenowitz, JS Gonzalez Journal of Diabetes and its Complications 30 (6), 1060-1068, 2016 | 72 | 2016 |
| Implementation of depression screening and global health assessment in pediatric subspecialty clinics E Iturralde, RN Adams, RC Barley, R Bensen, M Christofferson, SJ Hanes, ... Journal of Adolescent Health 61 (5), 591-598, 2017 | 58 | 2017 |
| Physical symptom complaints, cognitive emotion regulation strategies, self‐compassion and diabetes distress among adults with Type 2 diabetes NS Kane, CJ Hoogendoorn, ML Tanenbaum, JS Gonzalez Diabetic Medicine 35 (12), 1671-1677, 2018 | 56 | 2018 |
| The self-management experience of patients with type 2 diabetes and chronic kidney disease: a qualitative study S Shirazian, N Crnosija, K Weinger, AM Jacobson, J Park, ... Chronic illness 12 (1), 18-28, 2016 | 53 | 2016 |
| Trust in hybrid closed loop among people with diabetes: perspectives of experienced system users ML Tanenbaum, E Iturralde, SJ Hanes, SC Suttiratana, JM Ambrosino, ... Journal of health psychology 25 (4), 429-438, 2020 | 52 | 2020 |
| Adapting and validating a measure of diabetes-specific self-compassion ML Tanenbaum, RN Adams, JS Gonzalez, SJ Hanes, KK Hood Journal of Diabetes and its Complications 32 (2), 196-202, 2018 | 52 | 2018 |
| Disentangling clinical depression from diabetes-specific distress: Making sense of the mess we’ve made SA Esbitt, ML Tanenbaum, JS Gonzalez Screening for depression and other psychological problems in diabetes: A …, 2013 | 49 | 2013 |
| CGM benefits and burdens: two brief measures of continuous glucose monitoring LH Messer, PF Cook, ML Tanenbaum, S Hanes, KA Driscoll, KK Hood Journal of diabetes science and technology 13 (6), 1135-1141, 2019 | 43 | 2019 |
| Using cluster analysis to understand clinician readiness to promote continuous glucose monitoring adoption ML Tanenbaum, RN Adams, MS Lanning, SJ Hanes, BI Agustin, ... Journal of diabetes science and technology 12 (6), 1108-1115, 2018 | 41 | 2018 |
| Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: a mixed methods study LM Wu, ML Tanenbaum, MPJM Dijkers, A Amidi, SJ Hall, FJ Penedo, ... Social science & medicine 156, 80-89, 2016 | 41 | 2016 |
Jeffrey S. GonzalezYeshiva University and Albert Einstein College of MedicineVerified email at yu.edu
